BA
DPLO

Broadview Advisors’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Broadview Advisors’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-156,700
Closed -$3.04M – 103
2018
Q3 		$3.04M Sell
156,700
-108,100
-41% -$2.3M 0.52% 66
2018
Q2 		$6.77M Sell
264,800
-29,250
-10% -$682K 1.08% 47
2018
Q1 		$5.92M Sell
294,050
-43,950
-13% -$1.03M 0.97% 49
2017
Q4 		$6.78M Sell
338,000
-103,975
-24% -$2.04M 0.97% 43
2017
Q3 		$9.15M Sell
441,975
-4,425
-1% -$74.8K 1.33% 25
2017
Q2 		$6.61M Buy
446,400
+70,350
+19% +$1.17M 0.98% 46
2017
Q1 		$6M Buy
+376,050
New +$5.42M 0.83% 58

Other funds holding DPLO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Broadview Advisors's DPLO Position: Q4 2018 in Review

Broadview Advisors sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q4 2018, closing a stake of 156,700 shares — an estimated $3.04M sold.

Broadview Advisors first reported a position in DPLO in Q1 2017 and held it in 7 quarters. The position peaked at $9.15M in Q3 2017. 157 funds tracked by Wall St. Rank hold DPLO as of Q4 2018.

  • Broadview Advisors reported no remaining DIPLOMAT PHARMACY, INC. position as of Q4 2018 after selling out during the quarter.
  • Broadview Advisors sold 156,700 DIPLOMAT PHARMACY, INC. shares in Q4 2018, an estimated $3.04M.
  • Broadview Advisors first reported a position in DIPLOMAT PHARMACY, INC. in Q1 2017 and held it in 7 quarters.
  • Broadview Advisors's DIPLOMAT PHARMACY, INC. position peaked at $9.15M in Q3 2017.
  • 157 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q4 2018.

Based on Broadview Advisors's 13F filing for Q4 2018, filed 13 Feb 2019.